SHPH vs. TXMD, BMRA, KPRX, CLDI, PMCB, CHRO, TLPH, CSCI, RLMD, and BCLI
Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include TherapeuticsMD (TXMD), Biomerica (BMRA), Kiora Pharmaceuticals (KPRX), Calidi Biotherapeutics (CLDI), PharmaCyte Biotech (PMCB), Chromocell Therapeutics (CHRO), Talphera (TLPH), COSCIENS Biopharma (CSCI), Relmada Therapeutics (RLMD), and Brainstorm Cell Therapeutics (BCLI). These companies are all part of the "pharmaceutical products" industry.
Shuttle Pharmaceuticals vs.
TherapeuticsMD (NASDAQ:TXMD) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, community ranking, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.
TherapeuticsMD received 386 more outperform votes than Shuttle Pharmaceuticals when rated by MarketBeat users.
Shuttle Pharmaceuticals has a net margin of 0.00% compared to TherapeuticsMD's net margin of -207.77%. TherapeuticsMD's return on equity of -14.08% beat Shuttle Pharmaceuticals' return on equity.
Shuttle Pharmaceuticals has lower revenue, but higher earnings than TherapeuticsMD.
TherapeuticsMD has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.74, indicating that its share price is 274% less volatile than the S&P 500.
30.7% of TherapeuticsMD shares are owned by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 2.3% of TherapeuticsMD shares are owned by insiders. Comparatively, 39.6% of Shuttle Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Shuttle Pharmaceuticals had 4 more articles in the media than TherapeuticsMD. MarketBeat recorded 4 mentions for Shuttle Pharmaceuticals and 0 mentions for TherapeuticsMD. Shuttle Pharmaceuticals' average media sentiment score of 0.05 beat TherapeuticsMD's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.
Summary
TherapeuticsMD beats Shuttle Pharmaceuticals on 6 of the 11 factors compared between the two stocks.
Get Shuttle Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Shuttle Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:SHPH) was last updated on 1/25/2025 by MarketBeat.com Staff
